Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M5.9Revenue $M1.6Net Margin (%)-784.6Altman Z-Score-18.9
Enterprise Value $M-10.8EPS $-1.1Operating Margin %-891.6Piotroski F-Score3
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)-784.6Higher ROA y-yY
Price/Book0.410-y EBITDA Growth Rate %1.2Quick Ratio3.4Cash flow > EarningsN
Price/Sales2.25-y EBITDA Growth Rate %-26.9Current Ratio3.5Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-57.5Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-76.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M21.8ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with DCTH

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
DCTHGeorge Soros 2011-03-31 Sold Out $98.88 - $183.04
($136.89)
$ 0.27-100%Sold Out0
DCTHGeorge Soros 2010-12-31 Add$115.2 - $180.32
($151.15)
$ 0.27-100%Add 7.14%1,312
DCTHGeorge Soros 2010-09-30 Buy $88.48 - $139.04
($113.58)
$ 0.27-100%New holding1,225
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

DCTH is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


DCTH: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Taglietti MarcoDirector 2015-07-28Buy200,000$0.53-49.06view
STOLL ROGER G PHDDirector 2015-07-27Buy20,000$0.54-50view
Philips Laura ADirector 2015-07-23Buy162,653$0.5-46view
Rueckert William DodgeDirector 2015-07-22Buy20,000$0.48-43.75view
APPLING WILLIAM MEVP, R&D and Global Operations 2013-06-25Sell0$0-43.75view
APPLING WILLIAM MEVP, R&D and Global Operations 2013-06-25Sell0$0-43.75view
LEUNG GABRIELDirector 2012-06-15Buy469$25.12-98.93view
Koplewicz Harold SDirector 2012-06-01Buy4,167$23.84-98.87view
Purpura JohnEVP Reg. Affairs/Quality Assur 2012-06-01Buy313$23.84-98.87view
HOBBS EAMONN PPresident and CEO 2012-06-01Buy438$24.32-98.89view

Quarterly/Annual Reports about DCTH:

    News about DCTH:

    Articles On GuruFocus.com
    Five NCAV Companies for Value Investors – August 2015 Aug 04 2015 
    Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
    Delcath Systems Inc. Reports Operating Results (10-Q) Oct 23 2009 

    More From Other Websites
    Delcath announces Engagement of Lars E. Birgerson, M.D., Ph. D as global medical consultant Feb 11 2016
    DELCATH SYSTEMS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Feb 10 2016
    Delcath Announces Beginning Of Patient Enrollment In Phase 3 Focus Trial Feb 10 2016
    Delcath Systems to Present at Upcoming Investor Conferences Feb 04 2016
    DELCATH SYSTEMS, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and... Jan 22 2016
    Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System For Treatment Of Hepatic... Jan 20 2016
    Delcath Announces Initiation Of Phase 3 Trial Of Melphalan/HDS System For Treatment Of Hepatic... Jan 20 2016
    MicroCap Review Magazine Winter/Spring 2016 Issue Now Available Jan 19 2016
    Delcath Announces Special Protocol Assessment Agreement With FDA For New Phase 3 Trial In Hepatic... Jan 19 2016
    Delcath To Present At NobleCon12 Investor Conference Jan 15 2016
    Delcath To Present At NobleCon12 Investor Conference Jan 15 2016
    Review of Delcath Melphalan/HDS System Published in "Cardiovascular & Interventional Radiology" Jan 11 2016
    Delcath Prior Phase 3 Trial Results Published In Annals Of Surgical Oncology Dec 09 2015
    DELCATH SYSTEMS, INC. Financials Dec 08 2015
    Delcath Announces CHEMOSAT Review Accepted for Publication in Cardiovascular and Interventional... Dec 08 2015
    Delcath Announces CHEMOSAT Treatment Milestones In Europe Dec 02 2015
    DELCATH SYSTEMS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits Nov 25 2015
    Delcath Systems Inc Conference Call to discuss Business Update scheduled for 10:00 am ET today Nov 17 2015
    Delcath Systems To Host Business Update Conference Call On November 17, 2015 Nov 11 2015
    Delcath Systems To Host Business Update Conference Call On November 17, 2015 Nov 11 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK